# Immunovant, Inc.: Form 8-K, filed Aug 19, 2022

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 8-K
- Filed: 2022-08-19
- Accepted by EDGAR: Aug 19, 2022, 17:01 ET
- Period: 2022-08-17
- Accession: 0001764013-22-000108
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000176401322000108/imvt-20220817x8xk.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000176401322000108/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000176401322000108/imvt-20220817x8xk.htm

Filed Aug 19, 2022.
Source: SEC EDGAR, the filing index for accession 0001764013-22-000108. Last ingested by Listed: Nov 13, 2026, 16:26 ET. No prices; not investment advice.
